Jonsson Comprehensive Cancer Center
Clinical trials sponsored by Jonsson Comprehensive Cancer Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New PET tracer could spot cancers that standard scans overlook Results expected Sep 2026 (estimated)
- New MRI scan could spot brain tumors earlier Results expected Sep 2026 (estimated)
- Can your genes predict cancer? 2000-Patient study investigates Results expected Sep 2026 (estimated)
- New drug combo shows promise for tough lung cancer Results expected Oct 2026 (estimated)
- New Sugar-Based PET tracer could spot lung cancer sooner Results expected Oct 2026 (estimated)
-
Radiation implants take aim at inoperable kidney cancers
Disease control Stopped earlyThis early-phase study tests a type of internal radiation called brachytherapy for people with large kidney tumors (4-10 cm) that cannot be removed by surgery or ablation. A small radiation source is placed directly into the tumor to kill cancer cells. The goal is to see if this …
Phase 1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Immunotherapy boosts radiation against early lung cancer
Disease control Stopped earlyThis study investigates whether adding the immunotherapy drug durvalumab to stereotactic body radiation therapy (SABR) improves outcomes for people with early-stage non-small cell lung cancer who cannot have surgery. Participants are randomly assigned to receive either SABR alone…
Phase 1/2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope: drug may shield brain from CAR T-Cell therapy side effects
Disease control Stopped earlyThis study tested whether the drug anakinra could prevent severe brain inflammation (called ICANS) that sometimes happens after CAR T-cell therapy for certain types of lymphoma. The trial involved 23 adults whose lymphoma had returned or not responded to prior treatments. Researc…
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Laser zaps prostate tumors in tiny study
Disease control Stopped earlyThis study tested a new way to treat prostate cancer using a laser guided by MRI images. Only 2 men took part before the study was stopped. The goal was to see if the treatment was safe and could precisely target cancer while avoiding healthy tissue.
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC